Keynote and Plenary Speakers
Dr. Michael E. Gorman earned a PhD (1981) in Social Psychology at the University of New Hampshire. He is currently Director Science, Technology & Society at the University of Virginia and served as an STS Program Director at NSF. His research interests include social psychology of science, (Simulating Science, Indiana University Press, 1992); NSF supported work on cognition in the invention of the telephone (http://www2.iath.virginia.edu/albell/homepage.html) and engineering ethics (Gorman, Mehalik & Werhane, Ethical and Environmental Challenges to Engineering, Prentice-Hall, 2000). His current research is in the kind of interdisciplinary trading zones that will be needed for scientists, engineers and other stakeholders to collaborate on the development of new technologies (Trading Zones and Interactional Expertise: Creating New Kinds of Collaboration, MIT Press, 2010).
Dr. Laurence Bray is the Associate Chair of the Department of Bioengineering at George Mason University. She is responsible for overseeing a wide range of the department’s educational and research activities. Laurence also serves as the liaison to the department’s clinical partnership with the INOVA Health System, as well as other external partnerships, such the Food and Drug Administration. Her research interests are in studying the basic fundamentals of neuroscience using experimental, computational and behavioral approaches. Prior to joining Mason, Laurence was a postdoctoral fellow in the Department of Computer Science and Engineering in the Brain Laboratory at the University of Nevada, where she earned her PhD in Biomedical and Electrical Engineering. She graduated with her MS and BS degrees in Bioengineering and Biological Sciences, respectively from Clemson University.
Dr. Thomas P. Conrads – Biography forthcoming
Dr. Deborah Crawford joined George Mason University as Vice President for Research in April 2016. She is responsible for coordinating and overseeing the full range of the university’s research activities. Previously, she was with the International Computer Science Institute, an independent non-profit research organization affiliated with the University of California, Berkeley, where she served as President and Executive Director. From 2010 until 2014, she served as Senior Vice Provost for Research at Drexel University.
From 1993 to 2010, Crawford worked at the National Science Foundation (NSF) in executive and program management positions in the Directorates for Computer and Information Science and Engineering, Education and Human Resources, and Engineering, and in the Office of the Director. Crawford also served as NSF’s liaison to the National Science and Technology Council, the Office of Science and Technology Policy, and the National Institutes of Health. She was recognized by the President of the United States for her contributions to science and science policy, receiving a Presidential Rank Award in 2006 and in 2010.
Prior to joining NSF, Crawford’s research interests were in high-speed optical and optoelectronic systems in work done at the Jet Propulsion Laboratory, the University of California Santa Barbara, and AT&T Bell Laboratories.
A native of Glasgow, Scotland, Crawford earned her PhD in Information Systems Engineering from the University of Bradford, and her B.Sc. (Hons) in Electronic and Electrical Engineering from the University of Glasgow.
Mr. Jeffrey M. Gallagher, CEO of Virginia Bio, is responsible for leading the premier statewide trade group that promotes the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. Prior to taking on the leadership of Virginia Bio in May 2012, Jeff was a co-founder and served as VP & General Counsel for Lyotropic Therapeutics. This small specialty pharma company used its proprietary formulation technology to create new drug products based on both NCIs and already approved API for license, further development and commercialization by mid and large pharma. Previously he practiced corporate law in Richmond, focusing on new technology company formation, international business and intellectual property transactions. He was a co-founder and longtime Chairman of the Richmond based nonprofit World Pediatric Project. He holds an A.B. in Government from Harvard, a J.D. from the University of Wisconsin Law School, and an LL.M in Public International Law from the University of Virginia School of Law. He resides with his family in the Ginter Park area of Richmond, VA.
Dr. Michelle Harris-Love is associate professor in the Department of Bioengineering at George Mason University. She specializes in motor recovery following stroke, neural control of reaching movements, and non-invasive brain stimulation. Dr. Harris-Love earned a Master of Science degree in Physical Therapy at the Mayo School of Health Sciences and a PhD in Rehabilitation Science at the University of Maryland. She completed post-doctoral training in the Human Cortical Physiology Section at the National Institutes of Health in Bethesda, MD, and was a Functional Magnetic Resonance Imaging (MRI) Visiting Fellow at the Martinos Center for Biomedical Imaging, Harvard Medical School, Boston, MA. She has numerous peer-reviewed publications in journals such as the Journal of Neurophysiology, Neuroscience Letters, and Neurorehabilitation and Neural Repair; and her work has been funded by the National Institutes of Health, National Institute of Disability and Rehabilitation Research, Department of Defense, U.S. Department of Veterans Affairs, and the American Heart Association.
Dr. Andrew Lincoln is Director of the Sports Medicine Research Center for the MedStar Health Research Institute and Program Coordinator of the MedStar Sports Medicine Concussion Program. He specializes in the epidemiology of concussion and sports injuries and sports health policy, and coordinates research activity for the Sports Science and Safety Committee of US Lacrosse and the NFL Subcommittee on Cardiovascular Health. Dr. Lincoln is considered a national thought leader and leading researcher in the area of youth sports concussion.
Dr. Lincoln is the recipient of the NCAA Research Award and the O’Donoghue Award from the American Orthopaedic Society for Sports Medicine. His publications appear in prominent scientific and medical journals including the Journal of the American Medical Association (JAMA), Journal of Bone and Joint Surgery, and the American Journal of Sports Medicine. He serves on the editorial board for several leading medical journals, including Frontiers in Sports Neurology; he has been quoted in national publications, such as USA Today andThe Washington Post. He is actively involved in the American Public Health Association and the American College of Sports Medicine and provides consultation to government, sport governing bodies, and private organizations.
Dr. Lincoln received his bachelor’s degree in Engineering Science and Mechanics from Virginia Tech, his master’s degree in biomedical engineering from Louisiana Tech, and his doctorate in injury epidemiology from Johns Hopkins University. Dr. Lincoln has adjunct faculty appointments at the Johns Hopkins Bloomberg School of Public Health and the Uniformed Services University of Health Sciences, Bethesda, MD.
Dr. Emanuel Petricoin III has been the Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a University Professor. Prior to this position, he served as Co-Director of the FDA-NCI Clinical Proteomics Program and a Senior Investigator within the Center for Biologics Evaluation and Research at the FDA from 1993-2005. Dr. Petricoin received his PhD in Microbiology from the University of Maryland in 1990. The focus of the CAPMM is the invention and use of proteomics technologies for personalized therapy, and biomarker discovery and measurement for direct clinical applications at the bedside. He is a co-founder of 4 life science companies, Theranostics Health, Inc, Ceres Nanosciences Inc., C-4 Diagnostics, Inc. and Perthera, Inc. He is a co-inventor on 40 filed and published patents, and has authored over 350 peer-reviewed publications and invited reviews. He has authored over 40 book chapters, is on the editorial board of Proteomics, Biomedical Microdevices, Proteomics– Clinical Applications, Proteomics– Protocols, Molecular Carcinogenesis, Journal of Personalized Medicine and is a Senior Editor for Cancer Epidemiology Biomarkers and Prevention Dr. Petricoin is a founding member of the Human Proteomic Organization (HUPO) as well as the US HUPO and served on the Executive Committee and Treasurer for HUPO from 2002-2004. He has received numerous awards including the University Professorship at George Mason University, the NIH Director’s Award, FDA Distinguished Scientist Award, 2015 Innovator of the Year Award, GAP50 Top Virginia Entrepreneurs, Nifty 50 Award, American Society of Cytopathology Basic Research Award, the Roche Diagnostics/CLAS Distinguished Scientist Award and the Harvard University Leading Edge Award and is s Kentucky Colonel. He is the faculty representative to the George Mason University Research Foundation and represents GMU on the Board of Directors for the Virginia Health Research Biosciences Corporation.